contact : +90 533 232 80 38 zubeyde@aratistatistik.com
ANASAYFA / ÖRNEK ÇALIŞMALAR

OMEGA-CRO

2008-2013 yılları arasında, OMEGA kapsamında klinik ve saha çalışmalarının veri yönetimi ve istatistik analiz raporlarının organizasyonu, hazırlanması ve sonuçların yorumlanması.

Örnek çalışmalar:

http://www.tkd-online.org/dergi/TKDA_40_4_298_308.pdf

http://www.turkiyenintansiyonu.org/pdf/2011/TTO-Samsun-2011.pdf

http://www.ncbi.nlm.nih.gov/pubmed/20942865

Başkent Üniversitesi Hastanesi Uluslararası hakemli dergilerde yayınlanan makaleler :

1: Bilgic A, Akman B, Sezer S, Arat Z, Ozelsancak R, Ozdemir N. Daytime sleepiness and quality of life in peritoneal dialysis patients. Ther Apher Dial. 2011 Dec;15(6):565-71. doi: 10.1111/j.1744-9987.2011.00987.x. PubMed PMID:22107693.

2: Bilgic A, Akman B, Sezer S, Ozisik L, Arat Z, Ozdemir FN, Haberal M. Predictors for quality of life in continuous ambulatory peritoneal dialysis patients. Nephrology (Carlton). 2008 Oct;13(7):587-92. doi: 10.1111/j.1440-1797.2008.00970.x. Epub 2008 Jun 2. PubMed PMID: 18522701.

3: Sezer S, Elsurer R, Afsar B, Arat Z, Ozdemir NF, Haberal M. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients. Nephron Clin Pract. 2007;107(4):c156-62. Epub 2007 Oct 23. PubMed PMID: 17957127.

4: Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr. 2007 Nov;17(6):381-8. PubMed PMID: 17971310.

5: Sezer S, Ozdemir FN, Akman B, Arat Z, Anaforoglu I, Haberal M. Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2001;17:210-4. PubMed PMID: 11510278.

6: Sezer S, Ozdemir N, Arat Z, Güz G, Sengül S, Akman B, Haberal A, Turan M, Haberal M. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis? Adv Perit Dial. 2000;16:177-81. PubMed PMID: 11045288.

7: Bilgic A, Sezer S, Ozdemir FN, Akgul A, Arat Z, Haberal M. Clinical outcome after transfer from peritoneal dialysis to hemodialysis. Adv Perit Dial. 2006;22:94-8. PubMed PMID: 16983948.

8: Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients. Transplant Proc. 2009 Jun;41(5):1604-8. doi: 10.1016/j.transproceed.2008.12.034. PubMed PMID: 19545689.

9: Akgul A, Bilgic A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients. J Ren Nutr. 2008 Jul;18(4):338-46. doi:10.1053/j.jrn.2007.11.007. PubMed PMID: 18558298.

10: Sezer S, Bilgic A, Uyar M, Arat Z, Ozdemir FN, Haberal M. Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc. 2006 Mar;38(2):529-32. PubMed PMID: 16549166.

11: Akgul A, Bilgic A, Sezer S, Ozdemir FN, Olcay I, Arat Z, Haberal M. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients. Hemodial Int. 2007 Apr;11(2):198-203. PubMed PMID:17403171.

12: Akman B, Bilgic A, Sasak G, Sezer S, Sezgin A, Arat Z, Ozdemir FN, Haberal M. Mortality risk factors in chronic renal failure patients after coronary artery bypass grafting. Ren Fail. 2007;29(7):823-8. PubMed PMID: 17994450.

13: Sezer S, Ozdemir BH, Arat Z, Turan M, Ozdemir NF, Haberal M. Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients. Ren Fail. 2001 Nov;23(6):807-18. PubMed PMID:11777320.

14: Elsürer R, Sezer S, Ozdemir NF, Akgul A, Arat Z, Haberal M. Acute renal failure in intensive care unit: which factors predict future dialysis dependency? J Nephrol. 2006 Sep-Oct;19(5):634-9. PubMed PMID: 17136693.

15: Akman B, Afsar B, Ataç FB, Ibis A, Arat Z, Sezer S, Ozdemir FN, Haberal M. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list. Transplant Proc. 2006 Mar;38(2):413-5. PubMed PMID:16549134.

16: Ozdemir FN, Güz G, Sezer S, Arat Z, Turan M, Haberal M. Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients. Artif Organs. 2001 Jun;25(6):448-52. PubMed PMID:11453874.

17: Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Perit Dial Int. 2005 Feb;25 Suppl 3:S52-5. PubMed PMID: 16048257.

18: Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients. Ren Fail. 2009;31(3):196-200. doi:10.1080/08860220802669826. PubMed PMID: 19288324.

19: Ozdemir FN, Akcay A, Bilgic A, Akgul A, Arat Z, Haberal M. Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients. Transplant Proc. 2005 Sep;37(7):2918-21.PubMed PMID: 16213261.

20: Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. J Ren Nutr. 2005 Oct;15(4):427-34. PubMed PMID: 16198934.

21: Bilgic A, Ozdemir FN, Bayraktar N, Karakus S, Sasak G, Arat Z, Sezer S, Haberal M. Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients. Am J Nephrol. 2007;27(4):366-72. Epub 2007 Jun 13. PubMed PMID: 17570903.

22: Ozdemir FN, Akgul A, Altunoglu A, Bilgic A, Arat Z, Haberal M. The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients. Transplant Proc. 2007 May;39(4):990-2. PubMed PMID:17524871.

23: Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, Haberal M. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc. 2007 May;39(4):1023-6. PubMed PMID: 17524881.

24: Sezer S, Ozdemir FN, Arat Z, Turan M, Haberal M. Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients. Nephron. 2002 Jul;91(3):456-62. PubMed PMID: 12119477.

25: Ozdemir FN, Akçay A, Elsurer R, Sezer S, Arat Z, Haberal M. Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients. J Ren Nutr. 2005 Oct;15(4):371-6. PubMed PMID: 16198929.

26: Ozdemir NF, Elsurer R, Ibis A, Arat Z, Haberal M. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival. Transplant Proc. 2007 May;39(4):934-7. PubMed PMID: 17524855.

27: Akman B, Ozdemir FN, Colak T, Haberal A, Arat Z, Haberal M. Serum albumin and lymphocyte subsets as predictors of infection in renal transplant patients. Transplant Proc. 2003 Nov;35(7):2673-5. PubMed PMID: 14612067.

28: Sezer S, Uyar M, Arat Z, Ozdemir FN, Haberal M. Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Transplant Proc. 2005 Sep;37(7):3109-11. PubMed PMID: 16213322.

29: Nurhan Ozdemir F, Akcay A, Sezer S, Arat Z, Colak T, Turan M, Gulmus S, Haberal M. Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes. Transpl Immunol. 2004 Jun-Jul;13(1):39-42. PubMed PMID: 15203127.

30: Sezer S, Akgul A, Altunoglu A, Arat Z, Ozdemir FN, Haberal M. Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome. Transplant Proc. 2006 Mar;38(2):533-6. Erratum in: Transplant Proc. 2012 Nov;44(9):2893. Altinoglu, A [corrected to Altunoglu, A]. PubMed PMID:16549167.

31: Sezer S, Külah E, Ozdemir FN, Tutal E, Arat Z, Haberal M. Clinical consequences of intermittent elevation of C-reactive protein levels in hemodialysis patients. Transplant Proc. 2004 Jan-Feb;36(1):38-40. PubMed PMID:15013294.

32: Micozkadioglu H, Ozdemir FN, Sezer S, Arat Z, Haberal M. Weight gain after living-related renal transplantation affects long-term graft function. Transplant Proc. 2005 Mar;37(2):1029-32. PubMed PMID: 15848613.

33: Sezer S, Ozdemir FN, Elsurer R, Uyar M, Arat Z, Haberal M. Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal. Transplant Proc. 2005 Sep;37(7):2994-7. PubMed PMID: 16213283.

34: Tutal E, Sezer S, Afsar B, Arat Z, Ozdemir FN, Haberal M. Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients. Transplant Proc. 2006 Nov;38(9):2807-12. PubMed PMID:17112835.

35: Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M. The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients. Ren Fail. 2002 Jan;24(1):37-48. PubMed PMID: 11921697.

36: Kulah E, Sezer S, Uyar M, Arat Z, Ozdemir FN. Effects of ACE gene polymorphism on vitamin D therapy according to parathyroid hormone level in patients on hemodialysis. Adv Ther. 2006 Sep-Oct;23(5):778-86. PubMed PMID:17142213.

37: Sezer S, Akcay A, Ozdemir FN, Kulah E, Arat Z, Haberal M. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clin Transplant. 2004 Dec;18(6):722-5. PubMed PMID: 15516250.

38: Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M. Renal transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant. 2004 Oct;18(5):619-23. PubMed PMID: 15344970.

39: Ozdemir N, Güz G, Müderrisoglu H, Demirag A, Arat Z, Pekkara O, Haberal M. Ambulatory blood pressure monitoring in potential renal transplant donors. Transplant Proc. 1999 Dec;31(8):3369-70. PubMed PMID: 10616510.

40: Elsurer R, Afsar B, Sezer S, Arat Z, Ozdemir FN, Haberal M. Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients. Eur J Clin Nutr. 2008 Dec;62(12):1449-54. Epub 2007 Aug 1. PubMed PMID: 17671439.

41: Torun D, Sezer S, Arat Z, Pelit A, Yigit F, Ozdemir FN. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Int Heart J. 2005 Nov;46(6):1073-82. PubMed PMID: 16394603.

42: Akgul A, Ibis A, Sezer S, Basaran C, Usluogullari A, Ozdemir FN, Arat Z, Haberal M. Early assessment of renal resistance index and long-term renal function in renal transplant recipients. Ren Fail. 2009;31(1):18-24. doi: 10.1080/08860220802546347. PubMed PMID: 19142805.

43: Afsar B, Sezer S, Arat Z, Tutal E, Ozdemir FN, Haberal M. Reliability of mini nutritional assessment in hemodialysis compared with subjective global assessment. J Ren Nutr. 2006 Jul;16(3):277-82. PubMed PMID: 16825034.

44: Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M. Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs. 2002 Apr;26(4):366-70. PubMed PMID:11952508.

45: Güz G, Nurhan Ozdemir F, Sezer S, Işiklar I, Arat Z, Turan M, Haberal M. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis. 2000 Oct;36(4):826-36. PubMed PMID: 11007687.

46: Ozdemir FN, Güz G, Sezer S, Arat Z, Haberal M. Ambulatory blood pressure monitoring in potential renal transplant donors. Nephrol Dial Transplant. 2000 Jul;15(7):1038-40. PubMed PMID: 10862644.

47: Uyar M, Sezer S, Arat Z, Elsurer R, Ozdemir FN, Haberal M. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients. Transplant Proc. 2006 Sep;38(7):2069-73. PubMed PMID: 16980002.

48: Ozdemir FN, Sezer S, Güz G, Arat Z, Turan M, Haberal M. Is hepatitis C virus infection a risk factor for panel-reactive antibody positivity? Transpl Int. 2000;13 Suppl 1:S31-3. PubMed PMID: 11111957.

49: Sezer S, Uyar M, Akcay A, Arat Z, Kulah E, Ozdemir FN, Haberal M. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients. Transplant Proc. 2005 Mar;37(2):776-8. PubMed PMID: 15848528.

50: Sezer S, Ozdemir FN, Agca E, Colak T, Arat Z, Haberal M. Assessment of risk factors for chronic allograft nephropathy in renal transplant patients. Transplant Proc. 2003 Nov;35(7):2634-6. PubMed PMID: 14612048.

51: Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc. 2005 Sep;37(7):3119-20. PubMed PMID: 16213325.

52: Yakupoglu U, Ozdemir FN, Arat Z, Haberal A, Agca E, Bilgin N. Can troponin-I predict cardiovascular mortality due to myocardial injury in hemodialysis patients? Transplant Proc. 2002 Sep;34(6):2033-4. PubMed PMID: 12270303.

53: Akçay A, Ozdemir FN, Ataç FB, Sezer S, Verdi H, Arat Z, Haberal M. Angiotensin-converting enzyme genotype is a predictive factor in the peak panel-reactive antibody response. Transplant Proc. 2004 Jan-Feb;36(1):35-7.PubMed PMID: 15013293.

54: Arat Z, Sezer S, Ozdemir FN, Uyar M, Turan M, Haberal M. Predictors of hematopoietic response after renal transplantation. Transplant Proc. 2003 Nov;35(7):2716-7. PubMed PMID: 14612088.

55: Karakayali FY, Sevmis S, Basaran C, Yabanoglu H, Arat Z, Boyvat F, Haberal M. Relationship of preoperative venous and arterial imaging findings to outcomes of brachio-basilic transposition fistulae for hemodialysis: a prospective clinical study. Eur J Vasc Endovasc Surg. 2008 Feb;35(2):208-13. Epub 2007 Oct 24. PubMed PMID: 17920305.

56: Demirhan B, Bilezikçi B, Haberal AN, Sevmiş S, Arat Z, Haberal M. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection. Liver Transpl. 2008 Feb;14(2):214-9. doi:10.1002/lt.21360. PubMed PMID: 18236397.

57: Sakallioglu AE, Basaran O, Karakayali H, Ozdemir BH, Yucel M, Arat Z, Haberal M. Interactions of systemic immune response and local wound healing in different burn depths: an experimental study on rats. J Burn Care Res. 2006 May-Jun;27(3):357-66. PubMed PMID: 16679907.

58: Ozdemir FN, Akcay A, Sezer S, Boyacioglu S, Ozdemir BH, Arat Z, Haberal M. A six-year follow-up after interferon-alpha monotherapy for chronic hepatitis C infection in hemodialysis patients. Ren Fail. 2004 Sep;26(5):583-8. PubMed PMID: 15526919.

59: Ozdemir FN, Sezer S, Turan M, Colak T, Arat Z, Gülmüş S, Haberal M. The effect of simvastatin on panel-reactive antibody and crossmatch positivity. Transplant Proc. 2001 Aug;33(5):2842-3. PubMed PMID: 11498182.

60: Micozkadioğlu H, Colak T, Akçay A, Sezer S, Ataç FB, Verdi H, Arat Z, Ozemir FN, Haberal M. Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis. Transplant Proc. 2004 Jan-Feb;36(1):161-3. PubMed PMID: 15013333.

61: Akcay A, Sezer S, Ozdemir FN, Arat Z, Atac FB, Verdi H, Colak T, Haberal M. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation. 2004 Sep 27;78(6):892-8. PubMed PMID: 15385810.

62: Ozdemir FN, Miçozkadioğlu H, Ataç FB, Verdi H, Colak T, Ozdemir BH, Arat Z, Sezer S, Haberal M. The renin-angiotensin system and endothelial nitric oxide synthase gene polymorphisms and cyclosporine toxicity in renal transplant patients. Transplant Proc. 2004 Jan-Feb;36(1):128-30. PubMed PMID: 15013322.

63: Sezer S, Ozdemir FN, Güz G, Ozdemir BH, Sengül S, Arat Z, Turan M, Demirhan B, Haberal M. Ferritin levels can be a good predictor for HCV viremia in potential renal transplant candidates. Transplant Proc. 2001 Aug;33(5):2796-8. PubMed PMID: 11498163.

64: Ozdemir FN, Sezer S, Akcay A, Arat Z, Turan M, Gulmus S, Kulah E, Haberal M. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates. Transpl Immunol. 2004 Jan;12(2):185-8. PubMed PMID:14967317.

65: Ozdemir FN, Micozkadioglu H, Sezer S, Arat Z, Gürsoy M, Boyacioglu S, Haberal M. HCV antibody positivity significantly affects renal allograft survival. Transplant Proc. 2003 Nov;35(7):2701-2. PubMed PMID: 14612081.

66: Sezer S, Ozdemir FN, Güz G, Arat Z, Colak T, Sengul S, Turan M, Haberal A, Erdal R. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc. 2000 May;32(3):607-8. PubMed PMID:10812136.

67: Toprak MK, Cakir B, Ulu EM, Arat Z, Benli US, Can U, Ağildere M. The effects of interferon beta-1a on proton MR spectroscopic imaging in patients with multiple sclerosis, a controlled study, preliminary results. Int J Neurosci. 2008 Dec;118(12):1645-58. doi: 10.1080/00207450802309680. PubMed PMID: 18937112.

68: Ozdemir FN, Ibis A, Altunoglu A, Usluogullari A, Arat Z, Haberal M. Pretransplantation systolic blood pressure and the risk of delayed graft function in young living-related renal allograft recipients. Transplant Proc. 2007 May;39(4):842-5. PubMed PMID: 17524827.

69: Karakayali F, Ekici Y, Görür SK, Arat Z, Boyvat F, Karakayali H, Haberal M. The value of preoperative vascular imaging in the selection and success of hemodialysis access. Ann Vasc Surg. 2007 Jul;21(4):481-9. Epub 2007 Mar 26. PubMed PMID: 17379478.

70: Akcay A, Kanbay M, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients. Transplant Proc. 2005 Sep;37(7):3103-5. PubMed PMID:16213320.

71: Ozdemir FN, Micozkadioglu H, Arat Z, Turan M, Gulmus S, Haberal M. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients. Transplant Proc. 2004 Nov;36(9):2615-7. PubMed PMID: 15621103.

72: Ozdemir FN, Yakupoglu U, Turan M, Arat Z, Karakayali H, Erdal R, Turan M. Role of parathormone levels on T-cell response in hemodialysis patients. Transplant Proc. 2002 Sep;34(6):2044-5. PubMed PMID: 12270308.

73: Ozdemir FN, Akçay AT, Ozdemir BH, Turan M, Demirhan B, Colak T, Arat Z, Haberal M. Significance of diagnostic procedures for renal transplant graft function. Transplant Proc. 2002 Sep;34(6):2096-8. PubMed PMID: 12270328.

74: Bilezikçi B, Demirhan B, Sar A, Arat Z, Karakayali H, Haberal M. Hepatic stellate cells in biopsies from liver allografts with acute rejection. Transplant Proc. 2006 Mar;38(2):589-93. PubMed PMID: 16549182.

75: Karakus S, Arin BE, Arat Z, Karakayali H, Haberal M. Impact of hepatitis serology on development of leukopenia after solid organ transplantation. Transplant Proc. 2008 Jan-Feb;40(1):199-201. doi: 10.1016/j.transproceed.2007.12.012. PubMed PMID: 18261586.

76: Bilezikçi B, Demirhan B, Kocbiyik A, Arat Z, Haberal M. Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens. Transplant Proc. 2008 Jan-Feb;40(1):248-50. doi: 10.1016/j.transproceed.2007.11.054. PubMed PMID:18261599.

77: Bilezikçi B, Sahin F, Uyar P, Yilmaz Z, Demirhan B, Turan M, Arat Z, Haberal M. Frequency of recipient-derived chimerism and relationship with acute rejection and HLA tissue typing in transplanted livers. Transplant Proc. 2006 Mar;38(2):598-601. PubMed PMID: 16549185.

78: Haberal AN, Toru S, Ozen O, Arat Z, Bilezikçi B. Diagnostic pitfalls in the evaluation of fine needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases. Cytopathology. 2009 Apr;20(2):103-8. doi: 10.1111/j.1365-2303.2008.00594.x. Epub 2008 Aug 18. PubMed PMID: 18713250.

79: Haberal AN, Bilezikçi B, Ozen O, Yalçinkaya C, Arat Z, Kuşçu E, Demirhan B. Pap smear findings in chronic renal failure patients compared with the normal population according to Bethesda 2001. Diagn Cytopathol. 2008 Nov;36(11):776-9. doi: 10.1002/dc.20905. PubMed PMID: 18831015.

80: Sengul S, Arat Z, Ozdemir FN. Renal amyloidosis is associated with increased mortality in hemodialysis patients. Artif Organs. 2004 Sep;28(9):846-52. PubMed PMID: 15320948.

81: Ibis A, Altunoglu A, Akgül A, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Early onset proteinuria after renal transplantation: a marker for allograft dysfunction. Transplant Proc. 2007 May;39(4):938-40. PubMed PMID: 17524856.

82: Sakallioğlu AE, Başaran O, Ozdemir BH, Arat Z, Yücel M, Haberal M. Local and systemic interactions related to serum transforming growth factor-beta levels in burn wounds of various depths. Burns. 2006 Dec;32(8):980-5. Epub 2006 Oct 12. PubMed PMID: 17045746.

83: Boyvat F, Harman A, Ozyer U, Aytekin C, Arat Z. Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: direct simultaneous puncture of the portal vein and inferior vena cava. AJR Am J Roentgenol. 2008 Aug;191(2):560-4. doi: 10.2214/AJR.07.3496. PubMed PMID: 18647932.

84: Butros R, Boyvat F, Ozyer U, Bilezikci B, Arat Z, Aytekin C, Güvener N, Demirhan B. Management of infracentimetric thyroid nodules with respect to ultrasonographic features. Eur Radiol. 2007 May;17(5):1358-64. Epub 2006 Sep 20. PubMed PMID: 17021705.

85: Arat ZM, Türkkahraman H, English JD, Gallerano RL, Boley JC. Longitudinal growth changes of the cranial base from puberty to adulthood. A comparison of different superimposition methods. Angle Orthod. 2010 Jul;80(4):537-44. doi: 10.2319/080709-447.1. PubMed PMID: 20482360.

86: Uslu O, Arat ZM, Beyazoya M, Taskiran OO. Muscular response to functional treatment of skeletal open-bite and deep-bite cases: an electromyographic study. World J Orthod. 2010 Winter;11(4):e85-93. PubMed PMID: 21490994.

87: Arat FE, Arat ZM, Tompson B, Tanju S. Muscular and condylar response to rapid maxillary expansion. Part 3: magnetic resonance assessment of condyle-disc relationship. Am J Orthod Dentofacial Orthop. 2008 Jun;133(6):830-6. doi: 10.1016/j.ajodo.2007.03.026. PubMed PMID: 18538246.

88: Arat FE, Arat ZM, Tompson B, Tanju S, Erden I. Muscular and condylar response to rapid maxillary expansion. Part 2: magnetic resonance imaging study of the temporomandibular joint. Am J Orthod Dentofacial Orthop. 2008 Jun;133(6):823-9. doi: 10.1016/j.ajodo.2006.07.029. PubMed PMID: 18538245.

89: Arat FE, Arat ZM, Acar M, Beyazova M, Tompson B. Muscular and condylar response to rapid maxillary expansion. Part 1: electromyographic study of anterior temporal and superficial masseter muscles. Am J Orthod Dentofacial Orthop. 2008 Jun;133(6):815-22. doi: 10.1016/j.ajodo.2006.07.028. PubMed PMID: 18538244.

90: Arat ZM, Akcam MO, Esenlik E, Arat FE. Inconsistencies in the differential diagnosis of open bite. Angle Orthod. 2008 May;78(3):415-20. doi: 10.2319/021907-80.1. PubMed PMID: 18416610.

91: Altug-Atac AT, Erdem D, Arat ZM. Three-dimensional bimetric maxillary distalization arches compared with a modified Begg intraoral distalization system. Eur J Orthod. 2008 Feb;30(1):73-9. Epub 2007 Oct 18. PubMed PMID:17947349.

92: Arat ZM, Sezer FE, Arslan AD. A new approach in the treatment of skeletal open bite: vertically activated bite block. World J Orthod. 2006 Winter;7(4):345-56. PubMed PMID: 17190227.

93: Gumus A, Arat ZM. A removable Class II appliance for simultaneous distalization and expansion. J Clin Orthod. 2005 Oct;39(10):613-7. PubMed PMID:16244423.

94: Arat ZM, Arman A. Treatment of a severe Class III open bite. Am J Orthod Dentofacial Orthop. 2005 Apr;127(4):499-509. PubMed PMID: 15821695.

95: Arat ZM, Işeri H, Arman A. Differential diagnosis of skeletal open bite based on sagittal components of the face. World J Orthod. 2005 Spring;6(1):41-50. PubMed PMID: 15794041.

96: Arat ZM, Rübendüz M. Changes in dentoalveolar and facial heights during early and late growth periods: a longitudinal study. Angle Orthod. 2005 Jan;75(1):69-74. PubMed PMID: 15747818.

97: Arat ZM, Akçam MO, Gökalp H. Long-term effects of chin-cap therapy on the temporomandibular joints. Eur J Orthod. 2003 Oct;25(5):471-5. PubMed PMID:14609015.

98: Arat ZM, Gökalp H, Atasever T, Türkkahraman H. 99mTechnetium-labeled methylene diphosphonate uptake in maxillary bone during and after rapid maxillary expansion. Angle Orthod. 2003 Oct;73(5):545-9. PubMed PMID: 14580022.

99: Arat ZM, Rübendüz M, Akgül AA. The displacement of craniofacial reference landmarks during puberty: a comparison of three superimposition methods. Angle Orthod. 2003 Aug;73(4):374-80. PubMed PMID: 12940557.

100: Arat ZM, Gökalp H, Erdem D, Erden I. Changes in the TMJ disc-condyle-fossa relationship following functional treatment of skeletal Class II Division 1 malocclusion: a magnetic resonance imaging study. Am J Orthod Dentofacial Orthop. 2001 Mar;119(3):316-9. PubMed PMID: 11244427.

Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler :

1- Thyroid Function And Structural Abnormalities In Hemodialysis Patients S. Sezer, N. Özdemir, Z. Arat, G. Güz, Y. Erten, A. Haberal, S. Kaya, N. Bilgin European Renal Association, European Dialysis And Transplant Association XXXVth Annual Congress, 6-9 June, 1998 Rimini, Italy. Nephrology Dialysis Transplantation Vol. 13 N.6, A188 , 1998

2- A Different Aproach To The Catheter Infections In Hemodialysis Patients G. Güz, N. Özdemir, Z. Arat, H. Karakayalı, F . Boyvat, D. Güller, N.Bilgin,M. Haberal, European Renal Association, European Dialysis And Transplant Association Xxxvth Annual Congress, 6-9 June, 1998 Rimini, Italy. Nephrology Dialysis Transplantation Vol. 13 N.6, A204 , 1998

3- Effect Of Angiotensin Converting Enzyme Inhibitors Therapy To Erythropoietin Response In Hemodialysis Patiens G. Güz, N. Özdemir, Y. Erten, S. Sezer, M. Işıtman, Z. Arat, A. Haberal, N. Bilgin, M. Haberal European Renal Association, European Dialysis And Transplant Association Xxxvth Annual Congress, 6-9 June, 1998 Rimini, Italy. Nephrology Dialysis Transplantation Vol. 13 N.6, A246 , 1998

4- Does Low Interdialytic Weight Gain Indicate Malnutrition? S. Sezer, Fn. Özdemir, Ş. Şengül, P. Özyigit, T. Ünal, Z. Arat, M. Turan, M. Haberal Xxxvi Congress Of The European Renal Association European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain (Sözlü). Nephrology Dialysis Transplantation V.14, N.9; A193;1999

5- Hcv Infection In Hemodialysis Patients And Follow-Up After Cessation Of a- Ifn Treatment. Fn.Özdemir, S. Sezer, G. Güz, T. Ünal, Z. Arat, S. Boyacıoğlu, A.Haberal, M. Haberal. Xxxvi Congress Of The European Renal Association, European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain. (Best Abstract Presented By Young Author Grant) (Sözlü Nephrology Dialysis Transplantation V.14, N.9; A194;1999

6- Is There Any Effect Of Apolipoprotein E Polimorphyism On Serum Lipid,Lipoproteins And Atherosclerosis In Hemodialysis Patients? G. Güz, Fn. Özdemir, I. Işıklar, Z. Arat, M. Turan, M. Haberal. Xxxvi Congress Of The European Renal Association European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain. Nephrology Dialysis Transplantation V.14, N.9; A217;1999

7- Serum Immunoreactive Leptin Concentrations In Hemodialysis (Hd) Patients. Y.Erten, FN. Özdemir, Z. Arat, A. Haberal, M. Turan, M. Haberal. XXXVI Congress Of The European Renal Association European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain Nephrology Dialysis Transplantation V.14, N.9; A217;1999

8- Why Is CAPD More Atherogenic Than Hemodialysis? Fn Özdemir, G Güz, I Işıklar, S. Sezer, T Çolak, Z Arat, A Haberal, M Turan, M Haberal.XXXVI Congress Of The European Renal Association European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain. Nephrology Dialysis Transplantation V.14, N.9; A250;1999

9- Ambulatory Blood Pressure Monitoring In Potential Renal Transplant Donors. Fn.Özdemir, G.Güz, S. Sezer, Z. Arat, M. Haberal. Xxxvi Congress Of The European Renal Association European Dialysis And Transplant Association September 5-8, 1999 Madrid, Spain. Nephrology Dialysis Transplantation V.14, N.9; A316;1999

10- Clinical Experience And Natural Course Of Peritonitis Among CAPD Patients. FN.Özdemir, S. Sezer, G. Güz, Ş.Şengül, Z.Arat, C.Doğan, Ö.Pekkara, M.Haberal. 20 Th Annual Conference On Peritoneal Dialysis, San Francisco, California February 27-29,2000 Peritoneal Dialysis International V. 20,Suppl.1;S41; 2000

11- What Happens After Conversion Of Treatment To CAPD ? S,Sezer, Fn. Özdemir, Z.Arat, G.Güz, Ş.Şengül, B.Akman, A,Haberal, M.Turan, M.Haberal.20 Th Annual Conference On Peritoneal Dialysis, San Francisco, California February 27-29,2000 Peritoneal Dialysis International V. 20,Suppl.1;S70; 2000

12- Evaluation Of Depression In The Nurses Working In Our HD Unit. H.Ayaz, S.Akgün, B.Akman,Z.Arat,A.Sağduyu, D.Güller,G.Güz, S.Sezer, N.Özdemir, M.Haberal. 20 Th Dialysis Conference, Sanfransisco, California,Feb 27-29 2000 Peritoneal Dialysis International V. 20,Suppl.1;S 105; 2000

13- Autonomic Neuropathy In Elderly Hemodialysis Patients. S.Sezer, E.Tutal, FN.Özdemir, Ü.Yakupoğlu, G.Güz , Z.Arat, M.Turan, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A14; 2000

14- Serum Albumin Can Be A Predictor For Outcome Of Acute Renal Failure In Traumatic Rhabdomyolysis. (Sözlü) FN.Özdemir, Ü.Yakupoğlu, B.Akman, T.Çolak, Z.Arat, M.Turan, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A80; 2000

15- Dialysis In Patients With Diabetic Nephropathy: A Comparision Between Hemodialysis And CAPD. Ş.Şengül, FN.Özdemir, Z.Arat ,T. Çolak,M. Işıtman, M.Turan, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. . Nephrology Dialysis Transplantation V. 15, N.9; A99; 2000

16- Differences Between Multiple And Single Hepatitis Infections In Hemodialysis Patients. S. Sengül, Z.Arat,FN. Özdemir, S.Sezer, B.Demirhan, B.Bilezkci , M.Turan, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A106; 2000(Sözlü).

17- HCV Viremia And Correlation Of Liver Biopsy With Clinical Parameters In Hemodialysis Patients. S.Sezer, Bh.Özdemir, Ü.Yakupoğlu, Z.Arat , M.Işıtman, M.Turan FN.Özdemir, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association. First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France.Nephrology Dialysis Transplantation V. 15, N.9; A106; 2000

18- Malnutrition ; An Under Estimated Risk Factor For Atherosklerosis S.Sezer, FN.Özdemir, Z.Arat, Ş.Şengül, M.Turan, M.Haberal . XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A173; 2000(Sözlü).

19- The Risk Factors For Intact Pth Response And Vascular Calcification In Dialysis Patients. Ş.Şengül, FN.Özdemir, Z.Arat, S.Sezer, T.Unal, M.Turan, M.Haberal. XXXVII Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A207; 2000(Sözlü).

20- The Effect Of Simvastatin On Panel Reactive Antibody And Crossmatch Positivity. Best Abstract Presented By Young Author Grant) FN.Özdemir, S.Sezer, Z.Arat, M.Turan, G.Güz, Ş.Gülmüş, M.Haberal. Xxxvii Congress Of The European Renal Association, European Dialysis And Transplant Association First Combined Congress With European Kidney Research Association. Sept. 17-20 2000 Nice, France. Nephrology Dialysis Transplantation V. 15, N.9; A252; 2000(Sözlü).

21- Predictors Of Serum Albumin In Patients Receiving CAPD. S.Sezer, FN.Özdemir, B.Akman, Z.Arat, İ.Anaforoğlu, M.Haberal. 21 Th Annual Conference On Dialysis, New Orleans, Louisiana Feb. 19-21, 2001 Peritoneal Dialysis International V. 21,Suppl.1;S30; Feb.2001(Sözlü).

22- Intravenous Ascorbic Acid Administration For Erythropoietin Hyporesponsive Anemia In Iron Loaded Hemodialysis Patients. S.Sezer, FN.Özdemir, Ü.Yakupoğlu, Z.Arat, M.Turan, M.Haberal. (Sözlü). 21 Th Annual Conference On Dialysis, New Orleans, Louisiana Feb. 19-21, 2001 Peritoneal Dialysis International V. 21,Suppl.1;S80; Feb.2001

23- Factors Influencing Blood Pressure In Hemodialysis Patients S.Sezer, Fn.Özdemir, A.Doğruk, Z.Arat, P.Özyiğit, M.Haberal. 21 Th Annual Conference On Dialysis, New Orleans, Louisiana Feb. 19-21, 2001 Peritoneal Dialysis International V. 21,Suppl.1;S80; Feb.2001

24- New Intravenous Iron Policies In Hemodialysis Patients S.Sezer, Ü.Yakupoğlu, FN.Özdemir, Z.Arat, A.Haberal, M.Haberal. European Renal Association, European Dialysis And Transplant Association XXXVIII th Annual Congress 24-27 June, 2001, Vienna, Austria. Nephrology Dialysis Transplantation V. 16 N. 6 ; A136 , 2001

25-Cardiovascular Disease And Mortality In Hemodialysis Patients Ş.Şengül, FN.Özdemir, Z.Arat, M.Turan, R.Erdal, H.Karakayalı, M.Haberal. European Renal Association, European Dialysis And Transplant Association XXXVIII th Annual Congress 24-27 June, 2001, Vienna, Austria. Nephrology Dialysis Transplantation V. 16 N. 6 ; A149 , 2001

26- The Risks Of Hypoparathyroidism In Hemodialysis Patients Ş.Şengül, Z.Arat, FN.Özdemir, A.Haberal, M.Turan, R.Erdal, M.Haberal. European Renal Association, European Dialysis And Transplant Association XXXVIII th Annual Congress 24-27 June, 2001, Vienna, Austria. Nephrology Dialysis Transplantation V. 16 N. 6 ; A149 , 2001

27- Spectrum Of Liver Damage And Correlation With Clinical Parameters In Hemodialysis Patients. S. Sezer, BH.Özdemir, Z.Arat, M.Turan, FN.Özdemir, M.Haberal. ( Best Abstract Presented By Young Author) . European Renal Association, European Dialysis And Transplant Association Xxxviii Th Annual Congress 24-27 June, 2001, Vienna, Austria Nephrology Dialysis Transplantation V. 16 N. 6 ; A177 , 2001(Sözlü).

28- Predictors Of 2- Year Survival In Patients Starting CAPD Therapy S.Sezer, FN.Özdemir, B.Akman, H.Miçozkadıoğlu, Z.Arat, M.Haberal IX Congress Of The International Society For Peritoneal Dialysis June 26- 29, 2001, Montreal, Canada. Peritoneal Dialysis International : V. 21; Suppl 2; S71: 2001

29- Predictors Of Low Intact Parathyroid Hormone Levels In CAPD Patients FN.Özdemir, S.Sezer, Z.Arat, B.Budak, A.Haberal, M.Haberal. IX Congress Of The International Society For Peritoneal Dialysis June 26- 29, 2001, Montreal, Canada. Peritoneal Dialysis International : V. 21; Suppl 2; S84: 2001

30- A Survey Of The Peritonitis Of Our CAPD Patients Ü.Yakupoğlu, Fn.Özdemir, S.Sezer, Z.Arat, B.Akman, M.Haberal. IX Congress Of The International Society For Peritoneal Dialysis June 26- 29, 2001, Montreal, Canada. Peritoneal Dialysis International : V. 21; Suppl 2; S127: 2001

Uluslararası bildiri kitabında (Proceedings) basılan bildiriler :

31- Ambulatory Blood Pressure Monitoring In Renal Transplant Donors. N.Özdemir, G.Güz, H.Müderrisoğlu, A.Demirağ, Z.Arat, Ö.Pekkara, M.Haberal. Mesot Sixth International Congress Of The Middle East Society For Organ Transplantation Karachi-Pakistan, November 13-16, 1998. (Best Poster Award)

32- Is HCV Virus Infection A Risk Factor For Sensivity? FN Özdemir, S Sezer, G Güz, Z Arat, M Turan, M Haberal: XVthinternational Congress Of Nephrology, XIth Latinamerican Congress Of Nephrology, May 2-6, 1999, Buenos Aires Of Nephrology

33- Status Of HCV Infection And Hcv Viremia In Hemodialysis Patients S.Sezer, FN.Özdemir, G.Güz, B.Demirhan, BH.Özdemir, Ü.Yakupoğlu, Ş.Şengül, Z. Arat, A.Haberal, M.Turan, M.Haberal. IVth Congress Of Balkan Cities Association Of Nephrology, Dialysis, Transplantation And Artificial Organs, November 14-16, 1999, Izmir-Türkiye (Sözlü)

34- Ferritin Levels Can Be A Good Predictor For HCV Viremia In Potential Renal Transplant Candidates. S.Sezer, FN.Özdemir, G.Güz, B.Demirhan, BH.Özdemir, Ş.Şengül, Z.Arat, M.Turan, M.Haberal. VIIth International Congress Of The Middle East Society For Organ Transplantation. Beirut-Lebanon,June 8-11,2000

35- Factors Influencing Lymphocyte Subsets In Hemodialysis Patients FN.Özdemir, Ü.Yakupoğlu, A.Haberal, H.Miçoskadıoğlu, Z.Arat, M.Haberal. Nephroasia 2001; Conquering Current Challenges In Nephrology,13-16 June2001 Singapore 36- Tuberculosis Infection A Challenge To Diagnose And Treatment In Hemodialysis Patients.FN.Özdemir, S.Sezer, BH.Özdemir, E.Ağca, Z.Arat, M.Haberal Nephroasia 2001; Conquering Current Challenges In Nephrology,13-16 June 2001 Singapore

37-Is There A Relationship Between Dialysis Related Amyloidosis And Vascular Trombosis?Ü.Yakupoğlu,Fn.Özdemir, Z.Arat,M.Turan,M.Haberal. ASN/ISN World Congress Of Nephrology,October 10-17,2001 SanFrancisco,California,USA Journal Of The American Society Of Nephrology V 12, 2001, 306

38- Is There Any Relationship Between Depression And Malnutrition In Elderly HD Patients? B.Akman,A.Erol,FN.Özdemir, Z.Arat,R.Erdal,M.Haberal. ASN/ISN World Congress Of Nephrology,October 10-17,2001, San Francisco,California,Usa.Journal Of The American Society Of Nephrology V12,2001,366a

39- Can Troponin-I Predict Cardiovascular Mortality Due To Myocardial Injury In HD Patients?Ü.Yakupoğlu,E.Ağca,Fn.Özdemir,A.Haberal, Z.Arat,M.Haberal. Asn/Isn World Congress Of Nephrology,October 10-17,2001,San Francisco,California,Usa.Journal Of The American Society Of Nephrology V 12,2001,420a

40- Blood Pressure Varibility And Cardiovascular Death In Elderly HD Patients. B.Akman,FN.Özdemir,Ü.Yakupoğlu, Z.Arat,U.Tot,M.Haberal. Asn/Isn World Congress Of Nephrology,October 10-17,2001, San Francisco, California, Usa. Journal Of The American Society Of Nephrology V 12,2001,478a

41- Factors Influencing Lymphocyte Subsets In HD Patients FN.Özdemir, Ü.Yakupoğlu, A.Haberal,H. Miçozkadıoğlu, Z.Arat, M.Haberal.. 27th Annual Ashi Meeting October 13-17,2001,San Francisco,California,Usa Human Immunology Volume 62,Suppl.1,S101,2001.

42- Screening Of Antidonor Antibodies In Renal Post Transplant Patients:Preliminary Results FN.Özdemir, E.Ağca,Z.Arat,M.Turan,S.Sezer,M.Haberal 27th Annual Ashi Meeting October 13-17,2001,San Francisco,California,Usa Human Immunology Volume 62,Suppl.1,S122,2001.

43- Effect Of Graft Nepfrectomy On Erythropoetin Requirement After Chronic Renal Allograft Rejectio B.Akman,FN.Özdemir,Z.Arat,H.Miçozkadıoğlu,S.Baslak,M.Haberal. 22nd Annual Dialysis Conference March 4-6-2002,Tampa,Florida,Usa Peritoneal Dialysis International Vol.22,Suppl1,S18, 2002.(Sözlü)

44- Influence Of Peritoneal Transport Status On Atherosclerosis And Inflamation In PD Patients.S.Sezer,FN.Özdemir,H.Miçozkadıoğlu,Z.Arat,M.Haberal 22nd Annual Dialysis Conference March 4-6-2002,Tampa,Florida,Usa Peritoneal Dialysis International Vol.22,Suppl1,S30, 2002.(Sözlü)

45- Role Of Parathormone Levels On T-Cell Response In Hd Patients FN.Özdemir,Ü.Yakupoğlu,M.Turan,Z.Arat,M.Haberal 22nd Annual Dialysis Conference March 4-6-2002,Tampa,Florida,Usa Peritoneal Dialysis International Vol.22,Suppl1,S64, 2002.(Sözlü)

46- Risk Factors For Valvular Calcification In Patients More Than Three Years On Hd S.Sezer,FN.Özdemir,Z.Arat,E.Ağca,M.Haberal 22nd Annual Dialysis Conference March 4-6-2002,Tampa,Florida,Usa Peritoneal Dialysis International Vol.22,Suppl1,S66, 2002.(Sözlü)

47- Factors Contributing To Left Ventricular Hypertrophy In HD Patients Ü.Yakupoğlu,M.Uluçam,FN.Özdemir,A.Yıldırır,Z.Arat,M.Haberal 22nd Annual Dialysis Conference March 4-6-2002,Tampa,Florida,Usa Peritoneal Dialysis International Vol.22,Suppl1,S68, 2002.(Sözlü)

48- The Influence Of Simvastatin In The Treatment Of Highly Sensitized Dialysis Patients: The Long-TermPreAnd Post-Renal Transplantation Outcomes. FN. Özdemir,T.Çolak, M.Turan, A. Akçay,Ş.Gülmüş,Z.Arat,M.Haberal 16theuropean Histocompatibility Conference 19-22 March 2002 European Journal Of Immunogenetics April 2002 Volume 29(2),130 .(Sözlü)

49- The Importance Of A3 Allele Of HLA Class I And II In Response To Hepatitis B Vaccine In End Stage Renal Disease Patients H.Miçozkadıoğlu, FN.Özdemir, M.Turan, Z.Arat, Ü.Saatçi, M.Haberal 39 Th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1,108, 2002

50- Effect Of Parathyroid Hormone Levels And Inflammation On Atherosclerosis Of HD Patients Fn.Özdemir,Ü.Yakupoğlu,S.Sezer,U.Tot,Z.Arat,A.Haberal,M.Haberal. 39 Th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1,122, 2002

51- Peritoneal Transport Status And Clinical Concequences In CAPD Patients. S.Sezer,Z.Arat,A.Akçay,N.Özdemir,M.Turan,M.Haberal 39 Th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1,161, 2002

52- The Parathyroid Hormone Response In HD Patients. Z.Arat, S.Sezer, FN.Özdemir, E.Külah, B.Budak, M.Turan, M.Haberal Factors Influencing 39th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1,200, 2002

53- Determinants Of Ambulatory Blood Pressure In CAPD Patients S.Sezer,A.Akçay,Fn.Özdemir,M.Uluçam,Z.Arat,R.Erdal,M.Haberal 39 Th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1, 304, 2002

54- Risk Factors For Excessive Weight Gain In Patients Treated With CAPD S.Sezer, A.Akçay, FN.Özdemir,Z.Arat, B.Budak, A.Haberal, M.Haberal 39th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1, 304, 2002

55- Unexpected Risk Factor Of Left Ventricular Hypertrophy In HD Patients. Ü.Yakupoğlu,M.Uluçam,Z.Arat,FN.Özdemir,H.Müderrisoğlu,M.Haberal 39th Congress Of The European Renal Association European Dialysis And Transplant Association July 14-17,2002 Copenhagen,Denmark Nephrology Dialysis Transplantation Vol 17 Abstract Suppl 1, 120, 2002

56- Influence Of Parathyroid Hormone Levels On Renal Allograft Ourcome And Correlation With Histopatological Findings. S.Sezer,FN.Özdemir,Ü.Yakupoğlu,BH.Özdemir,Z.Arat,M.Turan,M.Haberal Poster XIX International Congress Of The Transplantation Society August 25-30 2002,Miami,Usa. Transplantation Vol 27(4) Suppl,450, 2002

57- Does Serum Albumin And Aminotransferase Levels Predict Renal Graft Outcome? A 5-Years Follow-Up Data Results. S.Sezer, FN.Özdemir, Z.Arat, E.Ağca, E.Külah, M.Turan, M.Haberal XIX International Congress Of The Transplantation Society August 25-30 2002,Miami,Usa. Transplantation Vol 27(4) Suppl,450, 2002 Poster

58-FN Özdemir, H Micozkadıoğlu, S Sezer, Z Arat, M Güroy, S Boyacıoğlu, M Haberal. HCV antibody positivity significantly effects renal allograft survival. The VIII International Congress of the Middle East Society for organ transplantation. Muscat, Sultanate of Oman, 21-24 Oct, 2002

59-S Sezer, Özdemir FN, T Çolak, Z Arat, M Haberal. Assesment of risk factrors for chronic rejection in renal transplant patients. The VIII International Congress of the Middle East Society for organ transplantation. Muscat, Sultanate of Oman, 21-24 Oct, 2002

60-Z Arat, S Sezer, FN Özdemir, M Uyar, M Turan, M Haberal. Predictrs of hematopoietic response after rnal transplantation. The VIII International Congress of the Middle East Society for organ transplantation. Muscat, Sultanate of Oman, 21-24 Oct, 2002

61-Ozdemir FN, Sezer S, Uyar M, Arat Z, Haberal M. Predictors of Acute renal Failure among patients undergoing coronary artery bypass surgery. 23RD Annul Conference on peritoneal Dialysis, March 2-4,2003 Seattle-Washington, USA. POSTER

62-D Torun, S Sezer, A Pelit, A Zümrütdal, Z Arat, FN Özdemir, M Haberal. Evaluation of target organ damage and ambulatory blood pressure monitoring in untreated hypertansive patients. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003) POSTER

63-E Külah, S Sezer, Z Arat, M Turan, FN Özdemir. Parathyroid gland stimulation and response to interferone therapy in HCV positive hemodialysis patients. World Congress of Nephrology, June 8 12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003) POSTER

64-A Akçay, FN Özdemir, FB Ataç, S Sezer, H Verdi, Z Arat, M Haberal. Angiotensin-converting enzyme genotype is a predictive factor in the peak panel ractive antibody response. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003) (Nephrol Dial Transp, vol:18, supp:4,2003) POSTER (Ödüllü)

65-H Miçozkadıoglu, T Çolak, A Akçay, S Sezer, FB Ataç, H Verdi, FN Özdemir, Z Arat, M Haberal. Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantaton erytrocytosis. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, POSTER (Nephrol Dial Transp, vol:18, supp:4,2003) (Ödüllü)

66-T Çolak, H Miçozkadıoğlu, FB Ataç, H Verdi, Z Arat, S Sezer, FN Özdemir, M Haberal. The renin-angiotensin systm and endothelial nitric oxide synthase gene polymorphism and cyclosporine toxicity in renal transplant patients. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003)POSTER

67-S Sezer, E Külah, FN Özdemir, E Tutal, Z Arat, M Haberal. Clinical consequences of intermittent elevation of C-reactive protein level in hemodialysis patients. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003)

POSTER

68-BH Özdemir, FN Özdemir, S Sezer, Z Arat, M Haberal. Among therapy modalities of end sage renal disease: renal transplantation improves survival in patients with amyloidosis. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003) POSTER

69- Ozdemir F, Turan M, Sezer S, Arat Z, Gulmus A, Kulah E, Haberal M. Panel- Reactive Antibody Positivity And Associated Hla- Antibodies In Turkish End-Stage Renal Disease Patients. TISSUE ANTIGENS. 2002 Dec;60(6):559.

70- Sezer S, Ozdemir F, Akcay A, Kulah E, Arat Z, Erdal R, Haberal M. Post-Transplant C-Reactive Protein Monitoring Predicts Chronic Rejection And Renal Allograft Survival.TISSUE ANTIGENS. 2002 Dec;60(6):558-559.

71- Turan M, Ozdemir F, Micozkadioglu H, Arat Z, Gulmus S, Haberal M. Importance Of A3 Allele Of Hla Class I In Response To Hepatitis B Vaccine In End- Stage Renal Disease Patients.TISSUE ANTIGENS. 2002 Dec;60(6):558.

72- Akcay A, Sezer S, Ozdemir F, Atac F, Verdi H, Terzioglu M, Arat Z, Colak T, Haberal M. Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism And Chronic Renal Transplant Dysfunction.TISSUE ANTIGENS. 2002 Dec;60(6):554.

73- Ozdemir F, Sezer S, Ozdemir B, Arat Z, Yakupoglu U, Turan M, Haberal M. Influence Of Parathyroid Hormone Level On Renal Allograft Outcome, And Correlation With Histopathological Findings.TISSUE ANTIGENS. 2002 Dec;60(6):552.

Ödüller :

1-AMBULATORY BLOOD PRESSURE MONITORING IN RENAL TRANSPLANT DONORS Özdemir N., Güz G, Müderrisoğlu H. Demirağ A. , Arat Z., Pekkara Ö.,Haberal M. MESOT Sixth International Congress Of The Middle East Society For Organ Transplantation Karachi-PAKISTAN, November 13-16, 1998. (Best poster award)

2-HCV INFECTION IN HEMODIALYSIS PATIENTS AND FOLLOW-UP AFTER CESSATION OF a- IFN TREATMENT. FN.Özdemir,S. Sezer,G. Güz,T. Ünal, Z. Arat, S.Boyacıoğlu, A.Haberal,M. Haberal Baskent University Faculty of Medicine, Dept, of Nephrology, Gastroenterology and Biochemistry, Ankara, Turkey XXXVI Congress of the European Renal Association European Dialysis and Transplant Association September 5-8, 1999 Madrid, Spain. ( First Best 8 abstract presented by young author)

3- THE EFFECT OF SIMVASTATIN ON PANEL REACTIVE ANTIBODY AND CROSSMATCH POSITIVITY. Özdemir FN, SezerS, Arat Z, Turan M, Güz G, Gülmüş Ş, Haberal M. Başkent University Faculty Of Medicine, Departments of Nephrology, and Biochemistry, Ankara, XXXVII Congress of the European Renal Association,European Dialysis and Transplant Association Sept. 17-20, 2000 Nice,France. ( Best abstract presented by young author )

4- SPECTRUM OF LIVER DAMAGE AND CORRELATION WITH CLINICAL PARAMETERS IN HEMODIALYSIS PATIENTS. S.Sezer, BH.Özdemir, Z.Arat, M.Turan, FN.Özdemir, M.Haberal Başkent University Faculty Of Medicine, Departments of Nephrology, Pathology and Biochemistry, Ankara, Turkey XXXVII Congress of the European Renal Association,European Dialysis and Transplant Association June 24- 27 2001, Vienna, Austria ( Best abstract presented by young author )

5-ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM SIGNIFICANTLY AFFECTS RENAL POSTTRANSPLANTATON ERYTROCYTOSIS. H Miçozkadıoglu, T Çolak, A Akçay, S Sezer, FB Ataç, H Verdi, FN Özdemir, Z Arat, M HaberalWorld Congress of Nephrology, June 8-12,2003, Berlin, Almanya, POSTER (Nephrol Dial Transp, vol:18, supp:4,2003) (Ödüllü)

6-ANGIOTENSIN-CONVERTING ENZYME GENOTYPE IS A PREDICTIVE FACTOR IN THE PEAK PANEL RACTIVE ANTIBODY RESPONSE. A Akçay, FN Özdemir, FB Ataç, S Sezer, H Verdi, Z Arat, M Haberal. World Congress of Nephrology, June 8-12,2003, Berlin, Almanya, (Nephrol Dial Transp, vol:18, supp:4,2003) (Nephrol Dial Transp, vol:18, supp:4,2003) POSTER (Ödüllü)

Ulusal hakemli dergilerde yayınlanan makaleler :

1- Özdemir FN, Sezer S, Turan M, Güz G, Arat Z, Gülmüş Ş, Haberal M, Hemodiyaliz hastalarında Panel Reaktif Antikor Düzeyini etkileyen parametreler. Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi 1999, 4;188-191

2- Sezer S, Özdemir FN, Güz G, Arat Z, Haberal A, Haberal M. Hemodiyaliz Hastalarında Tiroid Bezinin Fonksiyonel ve Yapısal Bozuklukları. Diyaliz Transplantasyon ve Yanık Dergisi, Aralık 1999 ; 11(1); 47-50

3- Sezer S, Arat Z, Özdemir FN. Kronik Böbrek Yetmezliğinde Malnutriyon. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 2000 ; 3 : 125-129

4- Sezer S, Yakupoğlu Ü, Arat Z, Akman B, Özdemir FN . Sürekli Ayaktan Periton Diyalizinin Kısa Dönem İzlemde Kardiyovasküler Sistem Üzerindeki Etkileri. Diyaliz Transplantasyon ve Yanık Dergisi, Haziran 2000; 11(2); 98- 103

5- Sezer S, Tutal E, Özdemir FN, Arat Z, Yakupoğlu Ü, Turan M, Haberal M. Hemodiyaliz Hastalarında Otonom Nöropati. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 2000 ; 9(4): 232-236

6- Sezer S, Miçozkadıoğlu H, Arat Z, Kut A, Turan M, Özdemir FN Eritropoez, Hemodiyaliz Hastalarında Homosistein Düzeylerini Belirleyebilir mi? Diyaliz Transplantasyon ve Yanık Dergisi,Ocak-Haziran 2002 13(1-2) 28-31

7- Sezer S, Ağca E, Arat Z, Doğruk A, Özdemir FN Hemodiyaliz Hastalarında Kan Basıncını Etkileyen Faktörler Diyaliz Transplantasyon ve Yanık Dergisi,Ocak-Haziran 2002 13(1-2) 31-36

8- Sezer s, Akçay A, Özdemir FN,Uluçam M,Arat Z, Haberal M Sürekliayaktan periton diyalizihastalarında sol ventrikülhipertrofisive ambulatuvar kan basıncının belirleyicileri,Türkiye Tıp Dergisi 2003; 10(2): 51-54

Ulusal bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler:

1- Hemodiyaliz Hastalarinda Kateter Enfeksiyonlarina Yeni Bir Yaklaşim. G. Güz, N. Özdemir, Z. Arat, H. Karakayali, F. Boyvat, D. Güller, N. Bilgin, M. Haberal. Xv. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 4-9 Ekim 1998, Izmir

2-Apolipoprotein E Genotipi Hemodiyaliz Hastalarinda Serum Lipid Lipoprotein Düzeyleri Ve Periferik Ateroskleroz Üzerine Etkili Mi ? G. Güz, F.N. Özdemir,I.Işıklar, Z. Arat, M. Turan, M. Haberal Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Mayıs 1999, Belek/Antalya

3- Hemodiyaliz Hastalarinda ACE Inhibitörlerinin Eritropoetin Cevabina Etkisi. G.Güz, F.N.Özdemir, Y.Erten, S.Sezer, M. Işıtman, Z. Arat, A.Haberal, N. Bilgin, M. Haberal Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Mayis 1999, Belek/Antalya

4- Hemodiyaliz Hastalarinda Hepatit B Virus Aşilamasina Yaniti Etkileyen Faktörler. S.Sezer, Fn.Özdemir, G.Güz, Ü.Yakupoğlu, Z.Arat, T.Çolak, Ş.Şengül, M.Turan, A.Haberal, M.Haberal Xvi. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

5- Hemodiyaliz Hastalarinin Verilen Hizmetlerden Memnuniyet Durumlarinin Değerlendirilmesi. I.İnanoğlu, S.Akgün, Z.Arat, D.Güller, P.Özyiğit, H.Ayaz, S.Kaya, N.Özdemir, (Hemşire Sunumu) Xvi. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

6- Hemodiyaliz Programindaki Hastalarin Tedaviye Uyumlarinda Sosyokültürel Seviye Önemlimidir?I.İnanoğlu, S.Arslan, P.Özyiğit, D.Güller, Z.Arat, N.Özdemir , M.Haberal Xvi. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

7- Hemodiyaliz Hastalarinda Arteriovenöz Fistül Lokalizasyonuna Göre Anevrizma Gelişimi. I.İnanoğlu, D.Güller, Z.Arat, A.Göktepe, E.Öksüz, S.Kaya, N.Özdemir,M.Haberal XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

8- Hemodiyaliz Hastalarinda Diyet Ve Hemşirelik Eğitiminin Algılanmasında Sosyodemografik Özelliklerin Etkisi P.Özyiğit, I.İnanoğlu, D.Güller, Z.Arat, S.Kaya, N.Özdemir XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

9- Hemodiyaliz Hastalarinda Arteriovenöz Fistüllerin Kullanilirlilik Süresi. I.İnanoğlu, Z.Arat, D.Güller, R.Papilla, A.Yılmaz, S.Avcı, A.Göktepe, S.Kaya N.Özdemir, M.Haberal XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

10- SAPD Peritonit Oluşumuna Etki Eden Faktörler Ö.Pekkara, Z.Arat, F.Üstündağ, F.Balaban, S.Kaya, N.Özdemir XVI Ulusal Nefroloji, Hipertansiyon, Diyaliz Ve Transplantasyon Kongresi, 16-18 Kasım, 1999, İzmir-Türkiye

11- Factors Influencing Response To Hepatitis B Virus Vaccination In Hemodialysis Patients. S.Sezer, Fn.Özdemir, T.Çolak, Z.Arat, Ş.Şengül, G.Güz, M.Turan, A.Haberal, M.Haberal. Doku Ve Organ Transplantasyonlarında Son Gelişmeler, 3-6 Kasım 1999,Kızılcıhamam, Ankara.

12- Birden Fazla Hepatit Virüsü İle Enfekte Hemodiyaliz Hastalarinin Özellikleri. Ş.Şengül, Z.Arat, Fn.Özdemir, S.Sezer, B.Demirhan, B.Bilezikçi, M.Turan, M.Haberal. Ii.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Nisan 2000, Belek, Antalya

13- Diabetik Nefropatisi Olan Hastalarda Hemodiyaliz Ve Sürekli Ambulatuar Periton Diyalizi Karşilaştirmasi Ş.Şengül, Fn.Özdemir, Z.Arat, T.Çolak, M.Işıtman, M.Turan, M.Haberal Ii.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Nisan 2000, Belek, Antalya

14- Hemodiyaliz Hastalarinda Mortalite Üzerine Akut Faz Yaniti Ve Yaşin Etkisi Ş.Şengül, Fn.Özdemir, B.Akman, G.Güz, S.Sezer, Z.Arat, T.Çolak, M.Turan, M.Haberal II Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Nisan 2000, Belek, Antalya

15- SAPD’nin Kisa Dönem Kardiyovasküler Sistem Üzerine Olan Etkileri. S.Sezer, B.Akman, Fn.Özdemir, Ü.Yakupoğlu, Z.Arat, T.Ünal, T.Çolak, M.Haberal. II.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 26-30 Nisan 2000, Belek, Antalya

16- Travmatik Rabdomiyolize Bağli Gelişen Akut Böbrek Yetmezliğinin İzleminde Serum Albumin Düzeyi Önemli Bir Gösterge Olabilir FN.Özdemir, Ü.Yakupoğlu, B.Akman, T.Çolak, Z.Arat, M.Turan, M.Haberal 17.Ulusal Nefroloji Hipertansiyon Diyaliz Ve Transplantasyon Kongresi. Türk Nefroloji Derneği Ve İnternasyonel Nefroloji Derneği Ortak Toplantısı, 2000 , İstanbul. (Sözlü)

17- Malnutrisyon : Ateroskleroz İçin Bir Risk Faktörü S.Sezer, Ş. Şengül, P.Özyiğit, Ü.Yakupoğlu, M.Turan, Z.Arat, FN.Özdemir, M.Haberal 17.Ulusal Nefroloji Hipertansiyon Diyaliz Ve Transplantasyon Kongresi. Türk Nefroloji Derneği Ve İnternasyonel Nefroloji Derneği Ortak Toplantısı, 2000, İstanbul

18- Beş Yılın Üzerinde Yaşayan HD Hastalarinda Yaşam Süresini Etkileyen Parametreler. FN.Özdemir, S.Sezer, Ş.Şengül, G.Güz, B.Akman, Z.Arat, M.Turan, M.Haberal 17.Ulusal Nefroloji Hipertansiyon Diyaliz Ve Transplantasyon Kongresi. Türk Nefroloji Derneği Ve İnternasyonel Nefroloji Derneği Ortak Toplantısı, 2000 , İstanbul

19- Diyaliz Hastalarinda Parathormon Yaniti Ve Vasküler Kalsifikasyon Gelişimini Etkileyen Faktörler. Ş. Şengül, N.Özdemir, Z.Arat, S.Sezer, T.Ünal, M.Turan, M.Haberal 17.Ulusal Nefroloji Hipertansiyon Diyaliz Ve Transplantasyon Kongresi. Türk Nefroloji Derneği Ve İnternasyonel Nefroloji Derneği Ortak Toplantısı, 2000 , İstanbul

20- Yaşli Hemodiyaliz Hastalarinda Otonom Nöropati S.Sezer, E.Tutal, Fn.Özdemir, Ü.Yakupoğlu, G.Güz, Z.Arat, M.Turan, M.Haberal 17.Ulusal Nefroloji Hipertansiyon Diyaliz Ve Transplantasyon Kongresi. Türk Nefroloji Derneği Ve İnternasyonel Nefroloji Derneği Ortak Toplantısı, 2000 , İstanbul

21- Hemodiyaliz Hastalarinda Kan Basincini Etkileyen Faktörler S.Sezer, Fn.Özdemir, A.Doğruk, Z.Arat, E.Ağca, M.Haberal Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi, 23- 27 Mayıs 2001,Antalya

22- Can Troponin-I Predict Cardiovascular Mortality Due To Myocardial Injury In Hemodialysis Patients? U. Yakupoglu, F. N. Ozdemir, Z. Arat, A. Haberal, E. Agca And N. Bilgin 25 Years In Renal Transplantation Congress Of Turkish Transplantation Society,November 79,2001,Kızılcıhamam,Ankara,Turkey. (Sözlü)

23- Role Of Parathormone Levels On T-Cell Response In Hemodialysis Patients. F. N. Ozdemir, U. Yakupoglu, M. Turan, Z. Arat, H. Karakayalı, R. Erdal And M. Turan 25 Years In Renal Transplantation Congress Of Turkish Transplantation Society,November 7-9,2001,Kızılcıhamam,Ankara,Turkey. (Sözlü)

24- Significance Of Diagnostic Procedures For Renal Transplant Graft Function F. N. Özdemir, A. T. Akçay, B. H. Özdemir, M. Turan, B. Demirhan, T. Çolak, Z. Arat And M. Haberal .. 25 Years In Renal Transplantation Congress Of Turkish Transplantation Society,November 7-9,2001,Kızılcıhamam,Ankara,Turkey. (Sözlü)

24- Aort Ve Mitral Kapak Kalsifikasyonlarinda Risk Faktörleri: 3 Yildan Daha Fazla Hemodiyalize Giren Hastalarda Yapilan Retrospektif Bir Çalişma. S.Sezer,Fn.Özdemir,Z.Arat,E,Ağca,M.Haberal Iv.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi 22-26 Mayıs 2002, Merit Limra Hotel,Kemer/Antalya. (Sözlü)

25- Hemodiyaliz Hastalarinda Kronik HCV Enfeksiyonunun Tedavisinde Inf-Alfanin Yeri: 5 Yillik Takip Çalişmasinin Sonuçlari. Fn.Özdemir,S.Sezer,A.Akçay,Bh.Özdemir,Z.Arat,M.Haberal Iv.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi 22-26 Mayıs 2002, Merit Limra Hotel,Kemer/Antalya. (Sözlü)

26- Hemodiyaliz Hastalarında T hücre Cevabı Üzerinde PTH Seviyelerinin Rolü FN.Özdemir,Ü.Yakupoğlu,M.Turan,Z.Arat,M.Haberal IV.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi 22-26 Mayıs 2002, Merit Limra Hotel,Kemer/Antalya.

27- Periton transport hızının periton diyalizi hastalarında görülen ateroskleroz ve inflamasyon üzerine etkisi S.Sezer,FN.Özdemir,H,Miçozkadıoğlu,Z.Arat,M.Haberal IV.Ulusal Hipertansiyon & Böbrek Hastalıkları Kongresi 22-26 Mayıs 2002, Merit Limra Hotel,Kemer/Antalya.

28- Panel Reactive Antibody(PRA) Positivity and Associated HLA Antibodies in Turkish end Stage Renal Disease Patients FN.Özdemir, M.Turan, S.Sezer, Z.Arat, Ş.Gülmüş, E.Külah, M.Haberal Doku Tiplendirmesi ve İmmunosuppresyon Sempozyumu Haziran 19-21 2002,Kızılcıhamam,Ankara,Türkiye (sözlü)

29- The relationship between ACE gene polymorphism and chronic allograft dysfunction in renal transplant patients. Akçay, S.Sezer, FN.Özdemir, FB.Ataç, H.Verdi, M.Terzioğlu,Z.Arat,T.Çolak, M.Haberal Doku Tiplendirmesi ve İmmunosuppresyon Sempozyumu Haziran 19-21 2002,Kızılcıhamam,Ankara,Türkiye (sözlü)

30- Renal Transplantation Offers a Better Survival in HCV Infected ESRD Patients S.Sezer,FN.Özdemir,M.Turan,S.Boyacıoğlu,Z.Arat,M.Haberal Doku Tiplendirmesi ve İmmunosuppresyon Sempozyumu Haziran 19-21 2002,Kızılcıhamam,Ankara,Türkiye (sözlü)

31- Post-Transplant C-Reactive Protein Monitoring Predicts Chronic Rejection And renal allograft survival. S.Sezer,FN.Özdemir,A.Akçay,E.Külah,Z.Arat,R.Erdal,M.Haberal Doku Tiplendirmesi ve İmmunosuppresyon Sempozyumu Haziran 19-21 2002,Kızılcıhamam,Ankara,Türkiye (sözlü)

32- The Importance Of A3 Allele Of HLA Class I And II In Response To Hepatitis B Vaccine In End Stage Renal Disease Patients M.Turan,FN.Özdemir,H.Miçozkadıoğlu,Z.Arat,Ş.Gülmüş,M.Haberal Doku Tiplendirmesi ve İmmunosuppresyon Sempozyumu Haziran 19-21 2002,Kızılcıhamam,Ankara,Türkiye (sözlü)

33- Eritropoez Hemodiyaliz Hastalarında Homosistein Düzeylerini belirleyebilirmi? S.Sezer,N. Özdemir, Z.Arat, A.Kut, M.Turan, M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 10,2002 (sözlü)

34- Hemodiyaliz Hastalarındaki Ateroskleroz Üzerine Paratiroid Hormon Düzeyleri Ve Inflamasyonun Etkisi. N.Özdemir,Ü.Yakupoğlu,S.Sezer,U.Tot,Z.Arat,A.Haberal,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 12,2002(sözlü)

35- Hemodiyaliz Hastalarında Sol Ventrikül Hipertrofisi Gelişiminde Endojen Eritropoetinin Rolü. Ü.Yakupoğlu,M.Uluçam,Z.Arat,N.Özdemir,H.Müderrisoğlu,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 12,2002(sözlü)

36- Son Dönem Böbrek Hastalarında Hepatit B Aşısına Cevapta A3 Alelin Önemi H.Miçozkadıoğlu,N.Özdemir,M.Turan,Z.Arat,Ü.Saatçi,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 17,2002(sözlü)

37- SAPD hastalarında aşırı kilo alımı için risk faktörleri S.Sezer, A.Akçay, N.Özdemir, Z.Arat, B.Budak, A.Haberal, M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 40,2002

38- SAPD Hastalarında Periton Transport Tipi Ve Klinik Sonuçları .S. Sezer,Z.Arat,A.Akçay,N.Özdemir,M.Turan,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye, Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 41,2002

39- SAPD Hastalarında Ambulatuvar Kan Basıncının Belirleyicileri Ve Sol Ventrikül hipertrofisi ile ilişkisi.S.Sezer,A.Akçay,N.Özdemir,M.Uluçam,Z.Arat,R.Erdal,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye,Türk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 41,2002

40- Hemodiyaliz Hastalarında PTH Cevabı Üzerine Etkili Faktörler

Z.Arat,S.Sezer,N.Özdemir,E.Külah,B.Budak,M.Turan,M.Haberal 19.Ulusal Nefroloji Hipertansiyon Diyaliz ve Transplantasyon Kongresi Eylül 18-21 2002 , Adora Hotel,Belek,Antalya,Türkiye,POSTERTürk Nefroloji Diyaliz ve Transplantasyon Dergisi Sayı 1,Suppl, 48,2002

Atıflara Örnekler

1- Haraki T, Takegoshi T, Kitoh C, Wakasugi T, Saga T, Hirai JI, Aoyama T, Inazu A, Mabuchi H.Carotid artery intima-media thickness and brachial artery flow-mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes

JOURNAL OF INTERNAL MEDICINE. 252 (2): 114-120 AUG 2002

2- Fresnedo GF, Rodrigo E, Escallada R, Cotorruelo JG, Ruiz JC, Zubimendi JA, de Francisco ALM, Arias M .Cardiovascular risk factors in renal transplantation: clinical markers. NEFROLOGIA,22:27-34,Suppl.4,2002

3- Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y. Advanced atherosclerosis in predialysis patients with chronic renal failure.KIDNEYINTERNATIONAL,61(6):2187-2192JUN,2002

4- Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC . Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis - National heart, lung, and blood institute family heart study STROKE , 33 (5): 1357-1361 MAY 2002

5- Nordfors L, Stenvinkel P, Marchlewska A, Weiss R, Heimburger O, Bergstrom J, Lindholm B, Schalling M. Molecular genetics in renal medicine: what can we hope to achieve? NEPHROLOGY DIALYSIS TRANSPLANTATION,17: 5-11 Suppl. 3 2002

6- Rodrigo E, Gonzalez-Lamuno D, Ruiz JC, Fernandez-Fresnedo G, Isla D, Gonzalez-Cotorruelo J, Zubimendi JA, De Francisco ALM, Garcia-Fuentes M

Apolipoprotein C-III and E polymorphisms cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation AMERICAN JOURNAL OF TRANSPLANTATION, 2 (4): 343-348APR2002

7-Pecoits R, Nordfors L, Lindholm B, Hoff CM, Schalling M, Stenvinkel P
Genetic approaches in the clinical investigation of complex disorders: Malnutrition, inflammation, and atherosclerosis (MIA) as a prototype
KIDNEY INTERNATIONAL 63: S162-S167 Suppl. 84 MAY 2003

8- Dietary lipids in the aetiology of Alzheimer's disease - Implications for therapy
Cooper JL DRUGS & AGING 20 (6): 399-418 2003

9- Genetics of intima-media thickness
Zannad F, Benetos A CURRENT OPINION IN LIPIDOLOGY 14 (2): 191-200 APR 2003

10- Apolipoprotein E polymorphism and atherosclerosis
Kolovou G, Daskalova D, Mikhailidis DP. ANGIOLOGY 54 (1): 59-71 JAN 2003

11-Ravona-Springer R, Davidson M, Noy S The role of cardiovascular risk factors in Alzheimer's disease CNS SPECTRUMS 8 (11): 824-831 NOV 2003

12-Liberopoulos EN, Elisaf MS Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients? OSTEOPOROSIS INT 14 (11): 957-957 NOV 2003

Atıf Yapılan Makale:

Guz G, Ozdemir FN, Sezer S, Isiklar I, Arat Z, Turan M, Haberal M
Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients AMERICAN JOURNAL OF KIDNEY DISEASES, 36 (4): 826-836 OCT 2000

ATIF YAPILDIĞI SAYI: 12

13- Levin NW, Ronco C . Chronic inflammation: An overview
Hemodıalysıs Technology Contrıbutıons To Nephrology 137: 364-370 2002

Atıf Yapılan Makale:

Ozdemir FN, Guz G, Sezer S, Arat Z, Turan M, Haberal M

Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients. ARTIFICIAL ORGANS, 25 (6): 448-452 JUN 2001

ATIF YAPILDIĞI SAYI: 1

14- Stephens MB, deGruy F. Does ambulatory blood pressure monitoring aid in the

management of patients with hypertension? JOURNAL OF FAMILY PRACTICE.51 (1): 15-15 JAN 2002

15- Blood pressure evaluation among older living kidney donors
Textor SC, Taler SJ, Larson TS, Prieto M, Griffin M, Gloor J, Nyberg S, Velosa J, Schwab T, Stegall M JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

14 (8): 2159-2167 AUG 2003

Atıf Yapılan Makale:

Ozdemir FN, Guz G, Sezer S, Arat Z, Haberal M

Ambulatory blood pressure monitoring in potential renal transplant donors
NEPHROLOGY DIALYSIS TRANSPLANTATION

15 (7): 1038-1040 JUL 2000

ATIF YAPILDIĞI SAYI: 2

16 - Menon V, Wang XL, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. AMERICAN JOURNAL OF KIDNEY DISEASES 42 (1): 44-52 JUL 2003

17- Konings CJAM, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, Bake AWV,vander Sande FM, Leunissen KML. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study
NEPHROLOGY DIALYSIS TRANSPLANTATION

18 (4): 797-803 APR 2003

Atıf Yapılan makale

Sezer, S., Özdemir, FN., Akman, B., Arat, Z., Anaforoğlu, I., Haberal, M., “Predictors of Serum Albumin in Patients Receiving CAPD” ‘ADVANCES IN PERITONEAL DIALYSIS. 17:210-4,2001

ATIF YAPILDIĞI SAYI: 2

18- Deicher R, Horl WH. Vitamin C in chronic kidney disease and hemodialysis patients
KIDNEY & BLOOD PRESSURE RESEARCH

26 (2): 100-106 2003. Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients

19- Mayer B, Zitta S, Greilberger J, Holzer H, Reibnegger G, Hermetter A, Oettl K Effect of hemodialysis on the antioxidative properties of serum
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

1638 (3): 267-272 JUL 30 2003

20- Kalantar-Zadeh K, Kopple JD Trace elements and vitamins in maintenance dialysis patients
ADV RENAL REPLACE TH 10 (3): 170-182 JUL 2003

21- Deira J, Diego J, Martinez R, et al. Comparative study of intravenous ascorbic acid versus low-dose desferroxamine in patients on hemodialysis with hyperferritinemia
J NEPHROL 16 (5): 703-709 SEP-OCT 2003

22- Nissenson AR, Charytan C Controversies in iron management
KIDNEY INT 64: S64-S71 Suppl. 87 NOV 2003

Atıf Yapılan makale

Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M

Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients.
ARTIFICIAL ORGANS 26 (4): 366-370 APR 2002

ATIF YAPILDIĞI SAYI: 5

23- Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients Szczech LA, Reddan DN, Klassen PS, Coladonato J, Chua B, Lowrie EG, Lazarus JM, Owen WF NEPHROLOGY DIALYSIS TRANSPLANTATION 18 (8): 1585-1591 AUG 2003

24- Takaki J, Nishi T, Shimoyama H, et al. Possible variances of blood urea nitrogen, serum potassium and phosphorus levels and interdialytic weight gain accounted for compliance of hemodialysis patients
J PSYCHOSOM RES 55 (6): 525-529 DEC 2003

25-Vincent JL, Dubois MJ, Navickis RJ, et al. Hypoalbuminemia in acute illness: Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials ANN SURG 237 (3): 319-334 MAR 2003

Atıf Yapılan makale

The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M
RENAL FAILURE 24 (1): 37-48 2002

ATIF YAPILDIĞI SAYI: 1

26- Recombinant hepatitis B vaccine (Engerix-B (R)) - A review of its immunogenicity and protective efficacy against hepatitis B
Keating GM, Noble S
DRUGS 63 (10): 1021-1051 2003

27- Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals
Idilman R, Colantoni A, De Maria N, Ustun C, Sam R, Ing TS, Akan H, Koc H, Van Thiel DH
HEPATO-GASTROENTEROLOGY 50 (49): 217-221 JAN-FEB 2003

28- Immunologic defects and vaccination in patients with chronic renal failure
Pesanti EL INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 15 (3): 813-+ SEP 2001

29- DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better
AM J KIDNEY DIS 42 (6): 1184-1192 DEC 2003

30- Aguilar P, Renoult E, Jarrosson L, et al. Anti-HBs cellular immune response in kidney recipients before and 4 months after transplantation
CLIN DIAGN LAB IMMUN 10 (6): 1117-1122 NOV 2003

Atıf Yapılan makale

Factors influencing response to hepatitis B virus vaccination in hemodialysis patients
Sezer S, Ozdemir FN, Guz G, Arat Z, Colak T, Sengul S, Turan M, Haberal A, Erdal R
TRANSPLANTATION PROCEEDINGS

32 (3): 607-608 MAY 2000

ATIF YAPILDIĞI SAYI: 3

31-Sahin I, Arabaci F, Sahin HA, et al. Does hepatitis C virus infection increase hematocrit and hemoglobin levels in hemodialyzed patients?
CLIN NEPHROL 60 (6): 401-404 DEC 2003

32- Herget-Rosenthal S, Gerken G, Philipp T, et al. Serum ferritin and survival of renal transplant recipients: a prospective 10-year cohort study
TRANSPLANT INT 16 (9): 642-647 SEP 2003

Atıf Yapılan makale

Ferritin levels can be a good predictor for HCV viremia in potential renal transplant candidates
Sezer S, Ozdemir FN, Guz G, Ozdemir BH, Sengul S, Arat Z, Turan M, Demirhan B, Haberal M TRANSPLANTATION PROCEEDINGS 33 (5): 2796-2798 AUG 2001

ATIF YAPILDIĞI SAYI: 2

33- Ossareh S, Ghorbani G, Ghods AJ Effect of HMG-CoA reductase inhibitors on reduction of panel reactivity TRANSPLANT P 35 (7): 2592-2593 NOV 2003

Atıf Yapılan makale

The effect of simvastatin on panel-reactive antibody and crossmatch positivity
Ozdemir FN, Sezer S, Turan M, et al.TRANSPLANTATION PROCEEDINGS
33 (5): 2842-2843 AUG 2001

ATIF YAPILDIĞI SAYI: 1

Twitter hesabımızdan en güncel haberleri, istatistikleri, verileri ve araştırma raporlarını anlık olarak takip etmek için lütfen tıklayınız.